ETFS Holding Theravance, Inc.

 
ETF Quotes for ETFS Holding Theravance, Inc. top ^
  • Holdings: Vector Group Ltd , Theravance Inc , UIL Holdings Corp , PBF Energy Inc Class A , Nu Skin Enterprises Inc Class A ,
  • Morningstar Rating: 5 Stars
Sign-up for des investment picks

 
Stock Quotes for Theravance, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for thrx investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for thrx investment picks

 
News Articles for Theravance, Inc. top ^
2014/12/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162917&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Biopharma Announces New Employment Inducement Awards investment picks
2014/12/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163707&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for REMINDER: Theravance Biopharma to Host Investor and Analyst Day on December 12th investment picks
2015/1/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167456&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Biopharma Announces New Employment Inducement Awards investment picks
2015/2/2
Phase 3 registrational studies of TD-4208 are anticipated to begin in 2015 GEORGE TOWN, Grand Cayman and PITTSBURGH , Feb.
Sign-up for Theravance Biopharma, Inc. and Mylan Partner to Develop and Commercialize a Novel LAMA Compound, TD-4208, for COPD investment picks
2015/2/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173709&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Announces FDA Advisory Committee to Review BREO(R) ELLIPTA(R) (FF/VI) for Asthma investment picks
2015/2/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173320&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the Leerink Global Healthcare Conference investment picks
2015/2/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173313&ProfileId=051205&sourceType=1 GEORGE TOWN, CAYMAN ISLANDS --
Sign-up for Theravance Biopharma to Present at the Leerink Global Healthcare Conference investment picks
2015/2/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173008&ProfileId=051205&sourceType=1 GEORGE TOWN, CAYMAN ISLANDS --
Sign-up for Theravance Biopharma Announces New Employment Inducement Awards investment picks
2015/2/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177040&ProfileId=051205&sourceType=1 GEORGE TOWN, GRAND CAYMAN --
Sign-up for Theravance Biopharma Enrolls First Patient in Phase 3 Registrational Study of Telavancin in Staphylococcus Aureus Bacteremia investment picks
2015/2/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177071&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance, Inc. Announces Cash Dividend of $0.25 per Share Payable to Stockholders of Record as of March 12, 2015 investment picks
2015/2/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1176149&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174778&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Report Fourth Quarter and Full Year 2014 Financial Results on February 18, 2015 investment picks
2015/2/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174175&ProfileId=051205&sourceType=1 GEORGE TOWN, GRAND CAYMAN --
Sign-up for Theravance Biopharma Initiates Patient Registry Study for VIBATIV(R) (telavancin) investment picks
2015/2/9
LONDON--GlaxoSmithKline PLC (GSK.LN) and Theravance Inc. (THRX) Monday announced the start of a second global phase III study to evaluate the effects of the investigational once-daily closed triple combination of fluticasone furoate/umeclidinium/vilanterol in patients with COPD.
Sign-up for Glaxo, Theravance Begin Second Global Phase III Lung Function Study investment picks
2015/2/9
http://media.marketwire.com/attachments/201404/74550_gsk.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173969&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA --
Sign-up for GSK and Theravance Announce Start of Phase III Lung Function Study With 'Closed' Triple Combination Treatment FF/UMEC/VI for COPD investment picks
2015/2/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177764&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the Cowen Healthcare Conference investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Theravance, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding the Hershey Company  |  Next: ETFS Holding Thor Industries, Inc.